Precigen Inc <PGEN.OQ> expected to post a loss of 6 cents a share - Earnings Preview
Precigen Inc PGEN.OQ PGEN.O is expected to show a rise in quarterly revenue when it reports results on March 19 for the period ending December 31 2024
The Germantown Maryland-based company is expected to report a 9.9% increase in revenue to $1.35 million from $1.23 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.
LSEG's mean analyst estimate for Precigen Inc is for a loss of 6 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Precigen Inc is $6.00, above its last closing price of $1.74.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | -0.08 | -0.08 | -0.09 | Missed | -12.5 |
Jun. 30 2024 | -0.10 | -0.10 | -0.10 | Met | -3.7 |
Mar. 31 2024 | -0.09 | -0.09 | -0.10 | Missed | -14.2 |
Dec. 31 2023 | -0.08 | -0.13 | Missed | -67.7 | |
Sep. 30 2023 | -0.08 | -0.08 | -0.08 | Met | -2.6 |
Jun. 30 2023 | -0.10 | -0.10 | -0.08 | Beat | 20 |
Mar. 31 2023 | -0.10 | -0.09 | -0.10 | Missed | -9.6 |
Dec. 31 2022 | -0.10 | -0.10 | -0.11 | Missed | -10 |
This summary was machine generated March 14 at 11:33 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
